Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
31.37 USD | -0.16% | -1.85% | -19.48% |
Feb. 12 | Craig-Hallum Adjusts Proto Labs Price Target to $38 From $30, Maintains Hold Rating | MT |
Feb. 09 | Transcript : Proto Labs, Inc., Q4 2023 Earnings Call, Feb 09, 2024 |
Summary
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
- For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
- For the last 4 months, the company has been enjoying highly positive EPS revisions, which were frequently and significantly raised.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
Weaknesses
- With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
- The company sustains low margins.
- With an expected P/E ratio at 32.45 and 28.01 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Industrial Machinery & Equipment
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-19.48% | 802M | C | ||
+11.73% | 82.35B | A- | ||
+20.17% | 71.09B | B | ||
+20.89% | 37.72B | B- | ||
+15.77% | 32.01B | A | ||
+9.19% | 27.2B | B- | ||
+3.18% | 26.74B | C+ | ||
+4.22% | 26B | B+ | ||
+16.93% | 25.5B | B+ | ||
+17.14% | 24.76B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- PRLB Stock
- Ratings Proto Labs, Inc.